Protein Sequencing Market Report 2026

The protein sequencing market size has grown rapidly in recent years. It will grow from $1.87 billion in 2025 to $2.06 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to expansion of biomedical research activities, increasing demand for protein structure analysis, growth of pharmaceutical R&D investments, availability of advanced analytical instruments, rising focus on molecular biology studies.

The protein sequencing market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing demand for personalized medicine research, rising investments in proteomics-based drug discovery, expansion of bioinformatics-enabled sequencing platforms, growing adoption of automated sequencing workflows, increasing focus on biomarker identification. Major trends in the forecast period include increasing adoption of high-throughput protein sequencing techniques, rising use of advanced mass spectrometry methods, growing integration of bioinformatics in sequencing workflows, expansion of custom protein sequencing services, enhanced focus on high-accuracy sequencing outputs.

The increase in genetic illnesses is expected to drive the growth of the protein sequencing market in the coming years. A genetic illness refers to any disease or condition caused by abnormalities or mutations in an individual’s genetic material, typically DNA. The growing incidence of genetic illnesses is primarily due to genetic mutations that may arise spontaneously or be inherited from parents. Protein sequencing plays an important role in identifying specific genetic variants responsible for diseases by enabling the detection of protein biomarkers, which are molecules that indicate a particular disease state or physiological condition. For example, in October 2024, according to the Cystic Fibrosis Trust, a UK-based national charity, 11,148 people were living with cystic fibrosis in the UK in 2022, which increased to 11,318 in 2023. Therefore, the rising prevalence of genetic illnesses is contributing to the growth of the protein sequencing market.

Major companies operating in the protein sequencing market are focused on developing technologically advanced and upgraded products, such as sequencing kits, to strengthen their competitive position. Sequencing kits consist of reagents, chemicals, and materials required for sample preparation and the execution of sequencing experiments. For instance, in February 2024, Quantum-Si, a US-based protein sequencing company, introduced Protein Sequencing Kit V2, an upgraded solution for its Platinum protein sequencing platform. This kit delivers enhanced sequencing performance through assay improvements, including the addition of a new amino acid recognizer, and supports the identification of unknown proteins using advanced analytical and inference tools. These enhancements offer improved sequencing accuracy, high reproducibility, the ability to identify unknown proteins, and a threefold reduction in cost per amino acid.

In October 2023, Thermo Fisher Scientific, a US-based biotechnology company, acquired Olink Holding AB for approximately $3.1 billion. This acquisition is expected to strengthen Thermo Fisher’s capabilities in the rapidly growing proteomics market by complementing its existing life sciences and mass spectrometry offerings. Olink Holding AB is a Sweden-based company focused on advancing proteomics research in collaboration with the scientific community across multiple disease areas to enable new discoveries and improve patient outcomes.

Major companies operating in the protein sequencing market are F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific SE, Beckman Coulter Inc, PerkinElmer Inc, GenScript Biotech Corporation, Agilent Technologies Inc, CeMIA SA, Shimadzu Corporation, Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc, SCIEX, Protein Metrics Inc, Alphalyse A S, Rapid Novor Inc, Creative Proteomics, Bioproximity LLC, Protagen AG, MS Bioworks LLC, Charles River Laboratories Inc.

North America was the largest region in the protein sequencing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the protein sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the protein sequencing market by increasing costs of imported analytical instruments, sequencing reagents, consumables, and advanced software platforms. Research institutions and pharmaceutical companies in North America and Europe are most affected due to reliance on imported high-precision equipment, while Asia-Pacific faces higher costs in service-based sequencing exports. These tariffs are raising operational expenses and extending procurement cycles. At the same time, they are encouraging local manufacturing of sequencing consumables, regional service provider expansion, and domestic development of bioinformatics solutions.

The protein sequencing market research report is one of a series of new reports that provides protein sequencing market statistics, including protein sequencing industry global market size, regional shares, competitors with a protein sequencing market share, detailed protein sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the protein sequencing industry. This protein sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein sequencing is the process of identifying the exact sequence of amino acids within a protein or peptide. This technique is employed to determine the specific arrangement of amino acids in a protein molecule, which is essential for understanding its structure and functional role in biomedical research.

The primary products and services in the protein sequencing market include protein sequencing products and protein sequencing services. Protein sequencing products consist of the tools and materials used to determine amino acid sequences in proteins. The key applications include biotherapeutics, genetic engineering, and other uses, and these solutions are utilized by end users such as pharmaceutical and biotechnology companies, along with other end users.

The protein sequencing market consists of revenues earned by providing services such as N-terminal protein sequencing, de novo amino acid sequencing, peptide mapping, de novo antibody sequencing, and amino acid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein sequencing also includes sales of mass spectrometry instruments and Edman degradation sequencers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.